Please add Atossa Therapeutics. Up and coming pharma company in the US.
+1 Have recently shown substantially positive news in breast cancer study, though alongside, walking away from bid of rival at a $6.5 Billion bid, as they did not want to pursue…
“Though the purchase would have given Atos scale to resist some pricing pressures, it wasn’t a perfect fit as the company looks to move toward high-growth digital services,”
+1 They seem to be doing quite well already
I’ve also requested this on the stock form, would definitely like to see this on FT